Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment
Johnson & Johnson announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a privately held biotechnology company specializing in...
Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...
India Targets 100 New Biologic Medicines by 2047 Under Biopharma SHAKTI
At the landmark 2nd Pharma Summit & Awards 2026 organized by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), the Government of...
Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times
Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving an overall subscription of 53.68 times...
AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
Sun Pharma Gets SBI Support for $12 Billion Organon Acquisition
State Bank of India (SBI) is set to join a global consortium financing Sun Pharmaceutical Industries Ltd.'s landmark USD 12 billion acquisition of Organon & Co.,...
